Business Context and Reporting Period
This Form 8-K, dated July 1, 2015, reports the completion of the spin-off of The Chemours Company from E. I. du Pont de Nemours and Company (DuPont). Effective prior to the opening of trading on July 1, 2015, DuPont distributed all outstanding shares of Chemours common stock to DuPont shareholders of record as of June 23, 2015. The transaction separated DuPont's Performance Chemicals reporting segment and certain other assets and liabilities into a distinct public company.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics for The Chemours Company. The document focuses exclusively on corporate governance, executive compensation, and the mechanics of the separation.
Material Changes
The primary material change is the legal and operational separation of Chemours from DuPont. Additionally, the filing details significant changes to executive compensation structures effective immediately following the spin-off, including the establishment of new base salaries and incentive targets for Named Executive Officers (NEOs).
Guidance, Outlook, and Management Commentary
The filing does not provide financial guidance or market outlook. Management commentary is limited to the Compensation Committee's principles for setting executive pay, which include establishing a strong link between pay and performance, aligning executive and stockholder interests, and driving long-term sustained stockholder value. The Committee reviewed benchmarking data from peer group companies to determine compensation levels.
Executive Compensation Details
On July 6, 2015, the Compensation Committee established the following compensation targets for NEOs (excluding CEO Mark P. Vergnano, whose targets were approved by independent directors):
| Name | Position | Base Salary | STIP Target (% of Base) | LTIP Target |
|---|---|---|---|---|
| Mark P. Vergnano | President and CEO | $900,000 | 130% | $3,930,000 |
| Mark E. Newman | SVP and CFO | $574,000 | 80% | $1,200,000 |
| E. Bryan Snell | President - Titanium Technologies | $400,000 | 75% | $800,000 |
| Thierry F.J. Vanlancker | President - Fluoroproducts | $598,799 | 60% | $371,595 |
| Elizabeth Albright | SVP Human Resources | $410,000 | 65% | $500,000 |
Note: Mr. Vanlancker is paid in Swiss francs; amounts converted to USD using the July 5, 2015 rate of 1.0617.
Spin-Off Adjustment Awards
In accordance with the Employee Matters Agreement, executives received replacement equity awards for DuPont grants forfeited during the spin-off. Key grants include:
- Mark P. Vergnano: 74,592 RSUs (replacing 2013 PSUs), 78,978 RSUs (replacing 2014 PSUs), and 331,231 Stock Options (replacing 2015 PSUs).
- Mark E. Newman: 197,161 Stock Options (replacing 2015 PSUs).
- Thierry F.J. Vanlancker: 11,045 RSUs (2013), 13,168 RSUs (2014), and 55,206 Stock Options (2015).
- Elizabeth Albright: 78,865 Stock Options (replacing 2015 PSUs).
Vesting schedules for these awards mirror the original DuPont PSU schedules, with vesting dates of March 1, 2016; March 1, 2017; and March 1, 2018.
Compensation Plans
Three plans became effective on the Effective Date:
- The Chemours Company Equity and Incentive Plan: Designed for recruitment, retention, and aligning interests with shareholders. Includes provisions for replacement awards.
- Director Deferred Compensation Plan: Allows directors to defer fees in cash or stock units until retirement.
- Management Deferred Compensation Plan: Allows participants to defer base salary and bonuses, with earnings mirroring company retirement savings plan investments.
Investor Verification Checklist
- Verify the exact number of shares distributed to DuPont shareholders on the Record Date (June 23, 2015) to confirm ownership stakes.
- Review the full text of the "Employee Matters Agreement" to understand the specific terms of the equity replacement awards.
- Examine the "Information Statement" (Exhibit 99.1 to the Form 10) for detailed peer group benchmarking data used to set executive salaries.
- Confirm the vesting conditions and performance metrics for the new STIP and LTIP awards, which are to be established by the Compensation Committee.
- Check subsequent filings for the initial financial results of Chemours as an independent entity, as this 8-K contains no financial performance data.